Jingru Tian

1.1k total citations · 2 hit papers
23 papers, 610 citations indexed

About

Jingru Tian is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Jingru Tian has authored 23 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jingru Tian's work include Systemic Lupus Erythematosus Research (8 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jingru Tian is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jingru Tian collaborates with scholars based in China, United States and Netherlands. Jingru Tian's co-authors include Dingyao Zhang, Yaqing Huang, Xu Yao, Qianjin Lu, Yi‐Ching Yang, Qianjin Lu, Ming Zhao, Vadim Kurbatov, Yadong Wang and Jin-Wei Cheng and has published in prestigious journals such as The EMBO Journal, Bioinformatics and Frontiers in Immunology.

In The Last Decade

Jingru Tian

21 papers receiving 600 citations

Hit Papers

Global epidemiology of sy... 2022 2026 2023 2024 2022 2023 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingru Tian China 9 249 217 97 90 77 23 610
Florence Ida Hsu United States 11 217 0.9× 269 1.2× 65 0.7× 156 1.7× 112 1.5× 26 985
Naonobu Sugiyama Japan 14 480 1.9× 359 1.7× 61 0.6× 46 0.5× 133 1.7× 34 871
Florian Meier Germany 12 266 1.1× 170 0.8× 204 2.1× 123 1.4× 280 3.6× 42 823
Sung‐Chao Chu Taiwan 11 287 1.2× 131 0.6× 86 0.9× 188 2.1× 264 3.4× 37 948
Ceara AE Walsh Ireland 10 394 1.6× 198 0.9× 82 0.8× 57 0.6× 84 1.1× 11 717
Samantha Griffini Italy 14 408 1.6× 359 1.7× 69 0.7× 55 0.6× 219 2.8× 26 923
Francesca Nencini Italy 17 205 0.8× 396 1.8× 86 0.9× 85 0.9× 47 0.6× 51 901
Takaharu Ikeda Japan 13 315 1.3× 155 0.7× 45 0.5× 50 0.6× 75 1.0× 51 500
Alba Erra Spain 15 421 1.7× 160 0.7× 107 1.1× 39 0.4× 123 1.6× 25 759
Adriana Lucía Vanegas-García Colombia 14 238 1.0× 191 0.9× 189 1.9× 23 0.3× 39 0.5× 47 491

Countries citing papers authored by Jingru Tian

Since Specialization
Citations

This map shows the geographic impact of Jingru Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingru Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingru Tian more than expected).

Fields of papers citing papers by Jingru Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingru Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingru Tian. The network helps show where Jingru Tian may publish in the future.

Co-authorship network of co-authors of Jingru Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Jingru Tian. A scholar is included among the top collaborators of Jingru Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingru Tian. Jingru Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Shuntong, Dingyao Zhang, Yaqing Huang, et al.. (2025). Relative sensitivity and preference of indicators in pharmaceutical trials of psoriasis and psoriatic arthritis. European journal of medical research. 30(1). 803–803.
2.
Tian, Jingru, et al.. (2025). New Mechanisms and Therapeutic Targets in Systemic Lupus Erythematosus. MedComm. 6(6). e70246–e70246. 2 indexed citations
3.
Tian, Jingru, Dingyao Zhang, Ming Zhao, et al.. (2024). Dysregulation in keratinocytes drives systemic lupus erythematosus onset. Cellular and Molecular Immunology. 22(1). 83–96. 7 indexed citations
4.
Tian, Jingru, Shuntong Kang, Dingyao Zhang, et al.. (2023). Selection of indicators reporting response rate in pharmaceutical trials for systemic lupus erythematosus: preference and relative sensitivity. Lupus Science & Medicine. 10(2). e000942–e000942. 2 indexed citations
5.
6.
Tian, Jingru, Shuntong Kang, Dingyao Zhang, et al.. (2023). Global, regional, and national incidence and prevalence of systemic sclerosis. Clinical Immunology. 248. 109267–109267. 19 indexed citations
7.
Zhang, Dingyao, Jingru Tian, Yadong Wang, & Jun Lü. (2022). Evitar: designing anti-viral RNA therapies against future RNA viruses. Bioinformatics. 38(9). 2437–2443.
8.
Tian, Jingru, Hang Zhou, Juan Liu, et al.. (2022). The Systemic Lupus Erythematosus Interventional Trials in Mainland China: A Continuous Challenge. Frontiers in Immunology. 13. 848478–848478. 1 indexed citations
9.
Tian, Jingru, Dingyao Zhang, Xu Yao, Yaqing Huang, & Qianjin Lu. (2022). Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Annals of the Rheumatic Diseases. 82(3). 351–356. 277 indexed citations breakdown →
10.
Tian, Jingru, Ping Yi, Juan Liu, et al.. (2022). The global burden of heterogeneity of lupus erythematosus interventional trials. Journal of Autoimmunity. 128. 102798–102798. 2 indexed citations
11.
Tian, Jingru, et al.. (2022). [Clinical features of children with Cunninghamella spp. infection: a case report and literature review].. PubMed. 42(5). 780–784. 1 indexed citations
12.
Zhang, Dingyao, Yutaka Matsubara, Jingru Tian, et al.. (2022). Bioinformatics identifies predictors of arteriovenous fistula maturation. The Journal of Vascular Access. 25(1). 172–186. 4 indexed citations
13.
Tian, Jingru, Dingyao Zhang, Vadim Kurbatov, et al.. (2021). 5‐Fluorouracil efficacy requires anti‐tumor immunity triggered by cancer‐cell‐intrinsic STING. The EMBO Journal. 40(7). e106065–e106065. 72 indexed citations
14.
Gao, Chao, et al.. (2021). The efficacy of dendritic cell vaccine for newly diagnosed glioblastoma: A meta-analysis of randomized controlled studies. Neurochirurgie. 67(5). 433–438. 7 indexed citations
15.
Xu, Hua, et al.. (2021). Management strategies and suggestions for in vitro fertilization laboratory during the epidemic period of novel coronavirus pneumonia. 41(5). 462–466. 1 indexed citations
16.
Tian, Jingru, et al.. (2018). Risk of adverse events from different drugs for SLE: a systematic review and network meta-analysis. Lupus Science & Medicine. 5(1). e000253–e000253. 26 indexed citations
17.
Zhang, Zhen, Xian Zhang, Ling Wei, et al.. (2017). Questionnaire to assess quality of life in patients with breast cancer – Validation of the Chinese version of the EORTC QLQ-BR 53. The Breast. 32. 87–92. 8 indexed citations
19.
Dai, Ziyu, Wenhua Lang, Hui Yang, et al.. (2017). Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer. Diseases of the Esophagus. 30(10). 1–7. 33 indexed citations
20.
Cheng, Jin-Wei, et al.. (2012). Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis. International Journal of Clinical Practice. 66(10). 917–923. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026